Phase 1B study of the safety and tolerability of the mineralocorticoid fludrocortisone acetate in patients with geographical atrophy

OBJECTIVE: To evaluate the safety and tolerability of a mineralocorticoid, in a single-dose intravitreal (IVT) injection of 1 mg/0.1 mL and 2 mg/0.1 mL fludrocortisone acetate (FCA) in subjects with geographical atrophy (GA) secondary to age-related macular degeneration. METHODS AND ANALYSIS: This p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Thomas, Chang, Andrew, Maddess, Ted, Provis, Jan, Penfold, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Retina
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252207/
https://www.ncbi.nlm.nih.gov/pubmed/36161841
http://dx.doi.org/10.1136/bmjophth-2022-001032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252207/
https://www.ncbi.nlm.nih.gov/pubmed/36161841
http://dx.doi.org/10.1136/bmjophth-2022-001032

Ejemplares similares